knowledge -WSS

knowledge

author：fashion 2025-09-07 14:13:15 - browse：74517

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Report: NIH

explore

WSS

After a drawn out lobbying fight, ARPA

Average age of first period drops to 11.9 years, study shows

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Lab trade group sues FDA to halt regulation of lab

Menendez indictment could see pharma lose a key ally

Menendez indictment could see pharma lose a key ally

hotspot

knowledge

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA seeks to regulate lab

The high cost of giving birth even with insurance

Kaiser Permanente unions announce official strike date

United colonoscopy coverage change 'may cost lives,' doctors say

Biohaven protein

Duchenne breakthrough therapy leaves behind pioneering families

Health insurers say they are turning to AI to cut costs, improve care

Medicare proposal to cover medical devices draws a mixed reaction

Health tech startups drop sharply from 2021 highs

Wikipedia

Did you have Obamacare on your GOP debate bingo card?

Medicare drug price negotiation program allowed for now

Sudafed saga points to U.S. issues with evaluating older drugs

Inequities make cancer less preventable for women: report

Data show record exodus of life scientists from academia

Stigma and the return of syphilis

focus

explore

Wikipedia

hotspot